glp 1 effects after stopping What Happens When You Stop GLP-1? GLP-1 Series: What Happens When

p.o., per oral administration in a tablet

Chronic Kidney Disease (CKD): Several companies are investigating the potential benefits of GLP-1 drugs in slowing the progression of CKD, a common complication of diabetes

Further research is essential to clarify their role and optimize their integration into perioperative management protocols for orthopedic patients

Additionally, metabolic syndrome milieu is one of the key contributors to development of Metabolic Associated Steatotic Liver Disease (MASLD), previously known as Non-Alcoholic Fatty Liver Disease (NAFLD)

*Average weight loss based on 68 and 72 week clinical trials studying semaglutide (2.4 mg) and tirzepatide (10-15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related health condition, the average weight loss was 15% and 20% respectively